-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Fennec Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Fennec Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.2M, a 412% decline year-over-year.
- Fennec Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.68M.
- Fennec Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$12.8M, a 43.5% increase from 2022.
- Fennec Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$22.6M, a 31.2% decline from 2021.
- Fennec Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$17.2M, a 3.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)